Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
Treats serious infections caused by susceptible anaerobic bacteria. Sold as Cleocin Hydrochloride. Every FDA application for this active ingredient: 1 branded and 14 generic.
As of Nov 15, 2026, FDA lists 15 applications for Clindamycin Hydrochloride (sold as Cleocin Hydrochloride), first approved Feb 22, 1970, with 3 new uses approved and 0 published complete response letters.
First approved: Feb 22, 1970
Applications: 15
New uses approved: 3
Complete response letters: 0
Medicare spending, 2025: $15.0M
Medicare Spending
CMS Part D and Part B, 2025, before manufacturer rebates; matched by generic name
Clindamycin HCl
Part D
$15.0M
-11%
1,490,396
Cleocin HCl
Part D
$0K
+42%
42
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
CLINDAMYCIN (PEDI) 75 MG/5 ML: $0.133 per MLGeneric · -19% in a year
CLINDAMYCIN 2% VAGINAL CREAM: $1.87 per GMGeneric · +19% in a year
CLINDAMYCIN HCL 150 MG CAPSULE: $0.105 per unitGeneric · -2% in a year
CLINDAMYCIN HCL 300 MG CAPSULE: $0.179 per unitGeneric · -2% in a year
CLINDAMYCIN HCL 75 MG CAPSULE: $0.269 per unitGeneric · -11% in a year
CLINDAMYCIN PHOSPHATE 1% FOAM: $1.97 per GMGeneric · -36% in a year
CLINDAMYCIN PHOSPHATE 1% GEL: $3.63 per MLGeneric · -55% in a year
CLEOCIN 100 MG VAGINAL OVULE: $60.24 per unitBrand · +3% in a year
CLEOCIN 2% VAGINAL CREAM: $1.79 per GMBrand · +2% in a year
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA
Pfizer
Teva
Sun Pharm Inds Ltd
Zydus Pharms USA
Aurobindo Pharma